| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2001 | US6284542 Incubating cells or tissue sample with a specimen of smooth muscle, measuring the oxidation metabolism of cells/tissue using a marker, detecting increase oxidation metabolism that is not a result of contractile demand for atp |
| 09/04/2001 | US6284538 Oligonucleotide used for diabetes and cancer treatment |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284489 Enzymatic polypeptide for use in screening bactericides; wound healing agents; for prevention of bacterial infections |
| 09/04/2001 | US6284464 Inhibition of binding of Hox and homeodomain-containing proteins and uses thereof |
| 09/04/2001 | US6284458 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 09/04/2001 | US6284289 Treatment of herpes infection with composition containing quaternary ammonium compound and an anti-viral agent |
| 09/04/2001 | US6284287 For administering drugs by breathing |
| 09/04/2001 | US6284275 Controlled release tablet having a unitary core |
| 09/04/2001 | US6284274 Analgesic tablet compositions |
| 09/04/2001 | US6284273 Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds |
| 09/04/2001 | US6284272 Pharmaceutical compositions containing an effervescent acid-base couple |
| 09/04/2001 | US6284271 Multiple unit effervescent dosage form |
| 09/04/2001 | US6284269 Pharmaceutical compositions of meloxicam with improved solubility and bioavailability |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | US6284266 Transdermal, heating the skin with an exothermic reaction |
| 09/04/2001 | US6284265 Antacid formulation |
| 09/04/2001 | US6284263 Buccal drug administration in the treatment of female sexual dysfunction |
| 09/04/2001 | US6284258 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 09/04/2001 | US6284255 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/04/2001 | US6284249 Fusion polypeptide having the C protein and E1 protein of hepatitis C virus |
| 09/04/2001 | US6284239 Murine model for human carcinoma |
| 09/04/2001 | US6284234 Topical delivery systems for active agents |
| 09/04/2001 | US6284226 Aerosol composition containing middle-chain fatty acid triglyceride dispersant |
| 09/04/2001 | US6284140 Dialysis solution for peritoneal dialysis |
| 09/04/2001 | CA2224062C Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 09/04/2001 | CA2125103C 6-piperazinyl-1h-pyrazolo¬3,4-b|pyridine-3-carboxylic acids, esters, amides and related compounds, a process for their preparation and their use as medicaments |
| 09/04/2001 | CA2086120C Topical ophthalmic suspensions |
| 09/04/2001 | CA2056067C A physical form of n-¬4-¬5-(cyclopentyloxcarbony)-amino-1-methylindol-3-yl-methyi|-3-methoxybenzoy1|-2-methyibezenesulphonanide, processes for its preparation and compositions containing it |
| 09/04/2001 | CA2045359C 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines |
| 09/04/2001 | CA2037410C Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 08/30/2001 | WO2001063539A2 Anti-infective agents useful against multidrug-resistant strains of bacteria |
| 08/30/2001 | WO2001063368A2 Compliance tracking method |
| 08/30/2001 | WO2001063244A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | WO2001062973A1 Antisense modulation of e2f transcription factor 3 expression |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 08/30/2001 | WO2001062950A1 Novel antibiotic wk-6150 and process for producing the same |
| 08/30/2001 | WO2001062949A1 Method of purifying a fermentation broth |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062933A2 Muteins of interleukin-13 (il-13) |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062900A1 Scytonemin and methods of using thereof |
| 08/30/2001 | WO2001062792A2 Cancer treatment and prognosis involving hes-1 protein |
| 08/30/2001 | WO2001062786A2 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062769A1 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 08/30/2001 | WO2001062765A2 Small molecule modulators of g protein-coupled receptor six |
| 08/30/2001 | WO2001062763A1 Method for inhibiting trypsin-type serine proteases |
| 08/30/2001 | WO2001062760A2 A NOVEL CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO[2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR |
| 08/30/2001 | WO2001062758A1 Pteridine compounds for the treatment of psoriasis |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062756A1 Pyridinylimidazoles |
| 08/30/2001 | WO2001062754A1 Method for the preparation of citalopram |
| 08/30/2001 | WO2001062751A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 08/30/2001 | WO2001062750A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 08/30/2001 | WO2001062747A1 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament |
| 08/30/2001 | WO2001062746A1 8,8a-dihydro-indeno[1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents |
| 08/30/2001 | WO2001062745A1 Substituted 8, 8a-dihydro-3ah-indeno[1,2-d]thiazoles, a method for their production and their use as medicaments |
| 08/30/2001 | WO2001062744A2 Substituted piperazine compounds |
| 08/30/2001 | WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 08/30/2001 | WO2001062737A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 08/30/2001 | WO2001062736A1 Aryl fused azapolycyclic compounds |
| 08/30/2001 | WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 08/30/2001 | WO2001062734A1 Process for producing quinolonecarboxylic acids and intermediates thereof |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062726A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/30/2001 | WO2001062723A1 VITAMIN D DERIVATIVES HAVING SUBSTITUENTS AT THE 2α-POSITION |
| 08/30/2001 | WO2001062721A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062717A1 Aminosulfonylbiphenyl derivatives |
| 08/30/2001 | WO2001062715A1 Novel cd23 inhibitors |
| 08/30/2001 | WO2001062714A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062713A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062712A1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands |
| 08/30/2001 | WO2001062709A2 Use of 2-phenylene diamine derivatives for the treatment of infections |
| 08/30/2001 | WO2001062706A1 Aminoadamantane derivatives as therapeutic agents |
| 08/30/2001 | WO2001062705A2 Aminoalcohol derivatives |
| 08/30/2001 | WO2001062704A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062668A2 Sulfur containing compounds |
| 08/30/2001 | WO2001062341A2 Combination product for the treatment of obesity |
| 08/30/2001 | WO2001062300A2 Caspase activated prodrugs therapy |
| 08/30/2001 | WO2001062297A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | WO2001062295A1 Drugs containing combined active ingredients |
| 08/30/2001 | WO2001062294A1 Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062293A1 Preventive or therapeutic drugs for various eosinophilia-related diseases containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062292A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062290A2 Methods and compositions for improving sleep |
| 08/30/2001 | WO2001062289A2 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/30/2001 | WO2001062286A1 Novel antibody with specificity for colon cancer |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001062278A1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
| 08/30/2001 | WO2001062275A1 Adjuvant treatment by in vivo activation of dendritic cells |
| 08/30/2001 | WO2001062266A2 Use of dpp-iv inhibitors for the treatment of diabetes |
| 08/30/2001 | WO2001062263A2 Use of pentosan polysulfate for the manufacture of a medicament for the treatment of male chronic pelvic pain syndrome |
| 08/30/2001 | WO2001062262A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 08/30/2001 | WO2001062261A1 Metalloproteinase inhibitors for the treatment of respiratory diseases |
| 08/30/2001 | WO2001062260A2 Improvement of implantation rate |
| 08/30/2001 | WO2001062259A1 Method of treatment of prostate cancer |
| 08/30/2001 | WO2001062258A2 Improvement of implantation rate using ff-mas |